From: Delta neutrophil index as an early marker of disease severity in critically ill patients with sepsis
Variables | Survivors (n = 56) | Nonsurvivors (n = 47) | p |
---|---|---|---|
Age | 62.6 ± 17.5 | 69.4 ± 12.4 | 0.081 |
Gender (male) | 35 (62.5%) | 33 (70.2%) | 0.410 |
Primary site of infection | Â | Â | Â |
   Lung | 26 (46.4%) | 30 (63.8%) |  |
   Intra-abdomen | 13 (23.2%) | 11 (23.4%) |  |
   Genitourinary | 13 (23.2%) | 6 (12.8%) |  |
   Skin and soft tissue | 3 (5.4%) | 0 (0%) |  |
   Others | 1 (1.8%) | 0 (0%) |  |
Severe sepsis/septic shock | 17 (30.4%) | 27 (57.4%) | 0.005 |
Overt DIC | 12 (21.4%) | 28 (59.6%) | < 0.001 |
Positive blood culture | 24 (42.8%) | 26 (55.3%) | 0.305 |
   Gram positive | 6 (10.7%) | 4 (8.5%) |  |
   Gram negative | 10 (17.8%) | 18 (38.3%) |  |
   Fungus | 8 (14.3%) | 4 (8.5%) |  |
   None detected | 32 (57.2%) | 21 (44.7%) |  |
SAPS 3 | 62.8 ± 13.6 | 76.5 ± 14.8 | < 0.001 |
SOFA score | 7.9 ± 4.2 | 11.7 ± 4.8 | < 0.001 |
Mechanical ventilation | 31 (55.4%) | 29 (61.7%) | 0.564 |
Renal replacement therapy | 12 (21.4%) | 24 (51.1%) | 0.002 |
Norepinephrine infusion | 1.4 ± 3.1 | 0.7 ± 1.3 | 0.107 |
Urine output (24 hours) | 2640.7 ± 1461.6 | 2543.9 ± 1434.6 | 0.791 |